Biomarkers for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macro-vascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

  • Prognostic Marker
  • Diabetic Neuropathic Marker
  • MolecMarker for Both Metabolic Syndrome & Hypoglycemia response
  • Genetic Lifestyle Interaction in the development & prevention of Diabetes

Related Conference of Biomarkers for Diabetes

July 17-18, 2017

18th European Diabetes Congress

Lisbon, Portugal
July 20-22, 2017

19thAsia Pacific Diabetes Conference

Melbourne, Australia
July 24-26,2017

10th Diabetologists Conference

Vancouver, Canada
September 20-22, 2017

International Conference on Diabetes and Diabetic Nursing Care

Charlotte, North Carolina, USA
October 30- November 1, 2017

9th Annual Congress on Endocrine Disorders and Therapies


(10 Plenary Forums - 1 Event)
Chicago, Illinois, USA
October 30-November 01, 2017

10th International Conference on Endocrinology

Chicago, Illinois, USA
December 04-05, 2017

25th Global Diabetes Summit and Medicare Expo

Dubai, UAE
February 12-13,2018

7th European Diabetes and Endocrinology Congress

Munich, Germany
March 08-09, 2018

17th Global Diabetes Conference and Medicare Expo

Paris, France

Biomarkers for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in